Last reviewed · How we verify
NCT05234528: LATIA
Life After Transient Ischemic Attack
trial in Transient Ischemic Attack in 355 participants. Participants enrolled and being followed up; not accepting new ones.
1 March 2024
Quick facts
| Lead sponsor | Aalborg University Hospital |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 355 |
| Start date | 1 February 2022 |
| Primary completion | 1 March 2024 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across Denmark |
Conditions studied
- Transient Ischemic Attack — all drugs for Transient Ischemic Attack →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Aalborg University Hospital
Who can join
18 and older, any sex, with Transient Ischemic Attack or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Transient ischemic attack (TIA) is defined as acute neurological symptoms of vascular origin, which resolves completely within 24 hours. However, emerging evidence indicates that up to 1/3 of patients is experiencing (non-focal) lasting symptoms, such as fatigue, depression, and anxiety. Aim: The aim of this study is to investigate self-reported lasting symptoms after TIA, timing of these symptoms as well as their potential resolution and characterize patients who have high risk for developing these symptoms. Method: This is a prospective cohort study which will include 350-400 patients with TIA from a single comprehensive stroke care center which serves the population in North Denmark Region, one of five administrative regions in Denmark (Stroke Unit, Aalborg University Hospital). Outcome measures include patient-reported outcomes collected at discharge, 3, 6 and 12 months and semi-structured interviews with a selected sample of patients. Perspective: This study will provide much needed insights into the development of lasting symptoms in patients with TIA in a cohort with presumed high external validity. Based on these results, a person-centered intervention will be designed to support the return to everyday life for patients with TIA.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Long-Term Fatigue Following Transient Ischemic Attack: A Prospective Cohort Study.
Ebbesen BH, Grøntved S, Hedegaard JN, Johnsen SP, et al · · 2025 · cited 3× · PMID 40367404 · DOI 10.1212/wnl.0000000000213605
Verify or expand the search:
- PubMed search for NCT05234528
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Transient Ischemic Attack
Currently open trials in the same condition.
- NCT07242768 — Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis · recruiting
- NCT06615726 — Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis · Phase 3 · active not recruiting
- NCT06515392 — TIA Scores' Mortality Predictions and Recurrent TIA and Stroke Prediction · recruiting
- NCT06653348 — Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke · Phase 2, PHASE3 · recruiting
- NCT06091319 — Florbetaben for Imaging of Vascular Amyloid · recruiting
Other Aalborg University Hospital trials
Trials by the same sponsor.
- NCT06960005 — ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease · NA · enrolling by invitation
- NCT06745544 — Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes · NA · recruiting
- NCT07185958 — Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy · not yet recruiting
- NCT07165574 — Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration · not yet recruiting
- NCT07173413 — Assessing the Quality of Telephone Follow-Up After Spine Surgery · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05234528 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aalborg University Hospital
- Last refreshed: 2 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05234528.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing